LENZ Therapeutics, Inc.

NasdaqGS:LENZ Stock Report

Market Cap: US$989.1m

LENZ Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:LENZ Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Jul 25SellUS$6,506,784Versant Venture Management, LLCCompany191,376US$34.00
27 Jun 25SellUS$6,093,000Versant Venture Management, LLCCompany200,000US$30.47
20 Jun 25SellUS$10,107,818Versant Venture Management, LLCCompany334,801US$30.35
10 Jun 25SellUS$10,150,000Versant Venture Management, LLCCompany350,000US$29.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LENZ?
Owner TypeNumber of SharesOwnership Percentage
General Public759,1562.66%
Individual Insiders777,3192.73%
Hedge Funds6,994,13824.5%
VC/PE Firms7,644,79626.8%
Institutions12,346,68743.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 91.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.7%
RA Capital Management, L.P.
4,178,823US$144.9m0%1.49%
12.7%
Alpha Wave Global, LP
3,612,211US$125.3m0%21.01%
12.2%
Versant Venture Management, LLC
3,465,973US$120.2m-23.7%49.93%
6.84%
Ridgeback Capital Management LLC
1,951,875US$67.7m0%52.43%
6.56%
Point72 Asset Management, L.P.
1,869,995US$64.9m3.79%0.11%
5.3%
Paradigm Biocapital Advisors LP
1,511,932US$52.4m96.2%1.86%
4.21%
The Vanguard Group, Inc.
1,199,462US$41.6m1.78%no data
4.09%
BlackRock, Inc.
1,166,511US$40.5m0.94%no data
3.43%
Sectoral Asset Management Inc.
977,245US$33.9m0%7.3%
3.03%
RTW Investments, LP
863,389US$29.9m0%0.35%
2.69%
Tang Capital Management, LLC
766,940US$26.6m0%1.07%
2.34%
UBS Asset Management AG
667,164US$23.1m676%no data
2.18%
James McCollum
620,599US$21.5m0%no data
1.89%
Adage Capital Management, L.P.
537,738US$18.6m0%0.03%
1.85%
Samsara BioCapital LLC
526,390US$18.3m-46.7%2.5%
1.26%
Geode Capital Management, LLC
360,392US$12.5m7.89%no data
1.08%
T. Rowe Price Group, Inc.
306,978US$10.6m-62.7%no data
1.01%
State Street Global Advisors, Inc.
287,356US$10.0m-41.9%no data
0.97%
Medical Strategy GmbH, Asset Management Arm
276,959US$9.6m0%0.54%
0.62%
Granahan Investment Management, LLC
176,166US$6.1m240%0.21%
0.61%
Morgan Stanley, Investment Banking and Brokerage Investments
175,115US$6.1m136%no data
0.5%
Alyeska Investment Group, L.P.
142,113US$4.9m0%0.02%
0.49%
Northern Trust Global Investments
140,954US$4.9m1.2%no data
0.43%
Charles Schwab Investment Management, Inc.
124,046US$4.3m0%no data
0.35%
Scoggin Capital Management LLC
100,000US$3.5m0%1.23%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/10 01:37
End of Day Share Price 2025/08/08 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

LENZ Therapeutics, Inc. is covered by 10 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason Matthew GerberryBofA Global Research
Yigal NochomovitzCitigroup Inc
Matthew CaufieldH.C. Wainwright & Co.